Concepedia

Richard A. Nugent

RA

Statistics

Publications

19

Citations

1.3K

H-Index

17

Active since

1982

Affiliations

Pfizer (United States)(Current)

W.E. Upjohn Institute for Employment Research

Integrated Nonclinical Development Solutions (United States)

Tetra Therapeutics (United States)

Scripps Research Institute

Richard A. Nugent is an author at Pfizer (United States) specializing in pharmacology, drug discovery, and medicinal chemistry.

Publications per year

1982–2020

19

Publications

19

Novel Mechanistic Class of Fatty Acid Amide Hydrolase Inhibitors with Remarkable Selectivity

Kyunghye Ahn, Douglas S. Johnson, Laura R. Fitzgerald et al. · Biochemistry · 2007 · 214 citations · Full text

, , +12

3-Aminopyrazole Inhibitors of CDK2/Cyclin A as Antitumor Agents. 1. Lead Finding

Paolo Pevarello, Maria Gabriella Brasca, Raffaella Amici et al. · Journal of Medicinal Chemistry · 2004 · 161 citations · Full text

, , +16

Structure-guided inhibitor design for human FAAH by interspecies active site conversion

Mauro Mileni, Douglas S. Johnson, Zhigang Wang et al. · Proceedings of the National Academy of Sciences · 2008 · 152 citations · Full text

, , +15

Pyrazoline bisphosphonate esters as novel antiinflammatory and antiarthritic agents

Richard A. Nugent, Megan Murphy, Stephen T. Schlachter et al. · Journal of Medicinal Chemistry · 1993 · 116 citations

, , +7

Design and Synthesis of Selective Phosphodiesterase 4D (PDE4D) Allosteric Inhibitors for the Treatment of Fragile X Syndrome and Other Brain Disorders

Mark E. Gurney, Richard A. Nugent, Xuesheng Mo et al. · Journal of Medicinal Chemistry · 2019 · 74 citations · Full text

, , +17

1–5 of 19